Regulatory T Cell Expression of Herpesvirus Entry Mediator Suppresses the Function of B and T Lymphocyte Attenuator-Positive Effector T Cells1

The binding of herpesvirus entry mediator (HVEM) to B and T lymphocyte attenuator (BTLA) is known to activate an inhibitory signaling cascade in effector T (Teff) cells, but we now report that the HVEM-BTLA pathway is also important to the suppressive function of regulatory T cells (Tregs). Although naive T cells up-regulated BTLA upon TCR activation, Treg expression of BTLA remained low, regardless of TCR activation. Moreover, BTLA−/− CD4+CD25+ Tregs had normal suppressive activity, whereas BTLA−/− Teff cells were more resistant than wild-type Teff cells to suppression by Tregs, suggesting BTLA expression by Teff cells was required for their suppression by Tregs. In contrast to BTLA, HVEM expression was comparable in naive Tregs vs Teff cells, but after stimulation HVEM expression was quickly down-regulated by Teff cells, whereas HVEM was further up-regulated by Tregs. HVEM−/− Tregs had decreased suppressive activity as compared with wild-type Tregs, indicating that Treg expression of HVEM was required for optimal suppression. Consistent with this, T cells from Scurfy mice (FoxP3 mutant) lacked HVEM gene expression, and adoptively transferred wild-type but not HVEM−/− Tregs were able to control alloresponses in vivo by normal Teff cells. Our data demonstrate that Tregs can exert their effects via up-regulation of the negative costimulatory ligand HVEM, which upon binding to BTLA expressed by Teff cells helps mediate the suppressive functions of Tregs in vitro and in vivo.

[1]  G. Freeman,et al.  CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator , 2008, Nature Immunology.

[2]  E. Wherry,et al.  Targeting of antigen to the herpesvirus entry mediator augments primary adaptive immune responses , 2008, Nature Medicine.

[3]  E. Olson,et al.  Deacetylase inhibition promotes the generation and function of regulatory T cells , 2007, Nature Medicine.

[4]  B. Li,et al.  Histone deacetylase inhibitors and transplantation. , 2007, Current opinion in immunology.

[5]  Q. Wang,et al.  Distinct expression and inhibitory function of B and T lymphocyte attenuator on human T cells. , 2007, Tissue antigens.

[6]  T. Whiteside,et al.  Expansion and characteristics of human T regulatory type 1 cells in co-cultures simulating tumor microenvironment , 2007, Cancer Immunology, Immunotherapy.

[7]  T. Whiteside,et al.  Selective Survival of Naturally Occurring Human CD4+CD25+Foxp3+ Regulatory T Cells Cultured with Rapamycin1 , 2007, The Journal of Immunology.

[8]  Wayne W. Hancock,et al.  Transcriptional Regulation by Foxp3 Is Associated with Direct Promoter Occupancy and Modulation of Histone Acetylation* , 2006, Journal of Biological Chemistry.

[9]  Shimon Sakaguchi,et al.  Foxp3+CD25+CD4+ natural regulatory T cells in dominant self‐tolerance and autoimmune disease , 2006, Immunological reviews.

[10]  C. Larsen,et al.  Transplant Tolerance in Non‐Human Primates: Progress, Current Challenges and Unmet Needs , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[11]  K. Murphy,et al.  Cutting Edge: B and T Lymphocyte Attenuator and Programmed Death Receptor-1 Inhibitory Receptors Are Required for Termination of Acute Allergic Airway Inflammation1 , 2006, The Journal of Immunology.

[12]  J. Kaye,et al.  Functional Analysis of B and T Lymphocyte Attenuator Engagement on CD4+ and CD8+ T Cells1 , 2005, The Journal of Immunology.

[13]  K. Murphy,et al.  Differential Effects of B and T Lymphocyte Attenuator and Programmed Death-1 on Acceptance of Partially versus Fully MHC-Mismatched Cardiac Allografts1 , 2005, The Journal of Immunology.

[14]  C. Benedict,et al.  Evolutionarily divergent herpesviruses modulate T cell activation by targeting the herpesvirus entry mediator cosignaling pathway. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[15]  M. Croft.  The evolving crosstalk between co-stimulatory and co-inhibitory receptors: HVEM-BTLA. , 2005, Trends in immunology.

[16]  K. Kintner,et al.  IL-12-Independent LIGHT Signaling Enhances MHC Class II Disparate CD4+ T Cell Alloproliferation, IFN-γ Responses, and Intestinal Graft-versus-Host Disease1 , 2005, The Journal of Immunology.

[17]  M. Colombo,et al.  Triggering of OX40 (CD134) on CD4(+)CD25+ T cells blocks their inhibitory activity: a novel regulatory role for OX40 and its comparison with GITR. , 2005, Blood.

[18]  K. Pfeffer,et al.  The role of herpesvirus entry mediator as a negative regulator of T cell-mediated responses. , 2005, The Journal of clinical investigation.

[19]  Wenjun Ouyang,et al.  A coreceptor interaction between the CD28 and TNF receptor family members B and T lymphocyte attenuator and herpesvirus entry mediator. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Ethan M. Shevach,et al.  Engagement of Glucocorticoid-Induced TNFR Family-Related Receptor on Effector T Cells by its Ligand Mediates Resistance to Suppression by CD4+CD25+ T Cells , 2004, The Journal of Immunology.

[21]  I. Ishikawa,et al.  Costimulation via Glucocorticoid-Induced TNF Receptor in Both Conventional and CD25+ Regulatory CD4+ T Cells1 , 2004, The Journal of Immunology.

[22]  W. Faubion,et al.  Cutting Edge: The Natural Ligand for Glucocorticoid-Induced TNF Receptor-Related Protein Abrogates Regulatory T Cell Suppression 1 , 2004, The Journal of Immunology.

[23]  H. Waldmann,et al.  Mouse glucocorticoid-induced tumor necrosis factor receptor ligand is costimulatory for T cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[24]  J. Allison,et al.  BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1 , 2003, Nature Immunology.

[25]  Yangxin Fu,et al.  Lymphotoxin β receptor‐Ig fusion protein treatment blocks actively induced, but not adoptively transferred, uveitis in Lewis rats , 2003, European journal of immunology.

[26]  S. Busfield,et al.  Modulation of LIGHT-HVEM Costimulation Prolongs Cardiac Allograft Survival , 2002, The Journal of experimental medicine.

[27]  J. Shimizu,et al.  Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-tolerance , 2002, Nature Immunology.

[28]  下崎 康治.  LIGHT,a TNF-Like Molecule,Costimulates T Cell Proliferation and Is Required for Dendritic Cell-Mediated Allogenic T Cell Response , 2001 .

[29]  W. Hancock,et al.  Requirement of the Chemokine Receptor CXCR3 for Acute Allograft Rejection , 2000, The Journal of experimental medicine.

[30]  C. Ware,et al.  B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator , 2005, Nature Immunology.

[31]  H. Waldmann,et al.  Regulatory T cells in transplantation tolerance. , 2005, Current topics in microbiology and immunology.

[32]  G. Freeman,et al.  The B7 family revisited. , 2005, Annual review of immunology.

[33]  金丸 史子.  Costimulation via glucocorticoid-induced TNF receptor in both conventional and CD25[+] regulatory CD4[+] T cells , 2004 .

[34]  D. Galas,et al.  Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse , 2001, Nature Genetics.